194 related articles for article (PubMed ID: 10847562)
1. Serum levels of coenzyme Q10 in patients with Alzheimer's disease.
de Bustos F; Molina JA; Jiménez-Jiménez FJ; García-Redondo A; Gómez-Escalonilla C; Porta-Etessam J; Berbel A; Zurdo M; Barcenilla B; Parrilla G; Enriquez-de-Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):233-9. PubMed ID: 10847562
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis.
Molina JA; de Bustos F; Jiménez-Jiménez FJ; Gómez-Escalonilla C; García-Redondo A; Esteban J; Guerrero-Sola A; del Hoyo P; Martínez-Salio A; Ramírez-Ramos C; Indurain GR; Arenas J
J Neural Transm (Vienna); 2000; 107(8-9):1021-6. PubMed ID: 11041280
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of coenzyme Q in patients with Lewy body disease.
Molina JA; de Bustos F; Ortiz S; Del Ser T; Seijo M; Benito-Léon J; Oliva JM; Pérez S; Manzanares J
J Neural Transm (Vienna); 2002 Sep; 109(9):1195-201. PubMed ID: 12203046
[TBL] [Abstract][Full Text] [Related]
5. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
6. Serum coenzyme Q10 and risk of disabling dementia: the Circulatory Risk in Communities Study (CIRCS).
Yamagishi K; Ikeda A; Moriyama Y; Chei CL; Noda H; Umesawa M; Cui R; Nagao M; Kitamura A; Yamamoto Y; Asada T; Iso H;
Atherosclerosis; 2014 Dec; 237(2):400-3. PubMed ID: 25463064
[TBL] [Abstract][Full Text] [Related]
7. Serum HDL, LDL and total cholesterol in patients with late-life onset of Alzheimer's disease versus vascular dementia.
Trkanjec Z; Béné R; Martinić-Popović I; Jurasić JM; Lisak M; Serić V; Demarin V
Acta Clin Croat; 2009 Sep; 48(3):259-63. PubMed ID: 20055246
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of coenzyme Q10 in patients with multiple sclerosis.
de Bustos F; Jiménez-Jiménez FJ; Molina JA; Gómez-Escalonilla C; de Andrés C; del Hoyo P; Zurdo M; Tallón-Barranco A; Berbel A; Porta-Etessam J; Parrilla G; Arenas J
Acta Neurol Scand; 2000 Mar; 101(3):209-11. PubMed ID: 10705945
[TBL] [Abstract][Full Text] [Related]
9. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study.
Wolters M; Hahn A
Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998
[TBL] [Abstract][Full Text] [Related]
10. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
[TBL] [Abstract][Full Text] [Related]
11. A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease.
Lee BJ; Yen CH; Hsu HC; Lin JY; Hsia S; Lin PT
Nutr Res; 2012 Oct; 32(10):751-6. PubMed ID: 23146771
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
Lee BJ; Huang YC; Chen SJ; Lin PT
Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
[TBL] [Abstract][Full Text] [Related]
13. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
14. Serum cholesterol levels and the risk of Parkinson's disease.
de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role.
Singh RB; Niaz MA
Int J Cardiol; 1999 Jan; 68(1):23-9. PubMed ID: 10077397
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase activity and dementia.
Wehr H; Bednarska-Makaruk M; Graban A; Lipczyńska-Łojkowska W; Rodo M; Bochyńska A; Ryglewicz D
J Neurol Sci; 2009 Aug; 283(1-2):107-8. PubMed ID: 19268306
[TBL] [Abstract][Full Text] [Related]
17. [Vascular risk factors in demented elderly: analysis of Alzheimer Clinic materials].
Czyzewski K; Pfeffer A; Wasiak B; Łuczywek E; Gołebiowski M; Styczyńska M; Barcikowska M
Neurol Neurochir Pol; 2001; 35(3):405-13. PubMed ID: 11732264
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21.
Miles MV; Patterson BJ; Chalfonte-Evans ML; Horn PS; Hickey FJ; Schapiro MB; Steele PE; Tang PH; Hotze SL
Pediatr Neurol; 2007 Dec; 37(6):398-403. PubMed ID: 18021919
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
[TBL] [Abstract][Full Text] [Related]
20. [Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
Shinkai T; Tominaga K; Shimabukuro Z; Shimizu E; Eguchi K; Saijo N; Iwashita K; Niitani H
Gan To Kagaku Ryoho; 1984 Jan; 11(1):87-96. PubMed ID: 6230057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
